Vaccinations

BioNTech’s £1 billion UK investment to drive jobs, growth and medical innovation

BioNTech, the German biopharmaceutical company behind one of the world's first COVID-19 vaccines, has announced a landmark investment of up to £1 billion in the UK over the next decade.

Israel’s vaccine data suggests that Pfizer is performing at the expected 95%

New vaccine data from Israel suggests that the double-dose of Pfizer is performing at the expected rate of 95% efficiency - with the possibility that it is performing even better than that being further investigated.

European Commission to create “transparency mechanism” for vaccine exports

In response to the AstraZeneca feud, EU officials are creating a "transparency mechanism" for vaccine exports - which would indirectly hold companies accountable for fulfilling their agreed contracts.

Moderna vaccine works on South African COVID mutation

The company announced that their current vaccine can handle the South African COVID mutation - with plans to create an "additional booster dose" to see if they can create specific protections against emerging variants.

UK is undecided about closing borders against COVID mutation

Tomorrow (26 January) the COVID 'O' meeting is expected to be a moment of decision-making about border policy, as the more infectious South African and Brazilian COVID mutations continue to circulate.

European Commission will get 60% less AstraZeneca vaccines

EU leaders are investigating why AstraZeneca are not following through with the pre-agreed number of vaccines for the Member States - taking a 60% cut to the expected amount.

Studies show promising results for new Oxford COVID-19 vaccine

Studies show that the new Oxford-produced RBD-SpyVLP COVID-19 vaccine produces a strong antibody response in mice and pigs.

The vital role of patient communications in the UK’s vaccination hubs

Paul Bensley, Managing Director at X-on, discusses how patient communications could be the only way to solve complex logistical considerations for mass vaccination.

Scientist warns UK not to rely on one dose of COVID vaccine

Professor Herb Sewell, expert in immunology, wrote that the UK Government should not rely on one dose of the vaccine - suggesting that the diluted vaccine could encourage mutations to evolve.

REACT study: There is “extreme pressure on healthcare services”

New data from the REACT study says that there have been more than 20 hospitals' worth of new patients since Christmas Eve, putting "extreme pressure" on the NHS.

COVID-19 spike proteins could evolve against immune responses

A new study suggests that COVID-19 spike proteins could evolve to disguise themselves from the human immune system.

European Commission outlines key actions to beat COVID-19

The European Commission has set out the key actions needed to step up the fight against the COVID-19 pandemic.

2,000 supply chain workers will be offered the COVID-19 vaccine

Up to 2,000 supply chain workers who are crucial to the delivery of the COVID-19 vaccine will be offered the vaccination themselves.

Over 4 million people receive first dose of COVID-19 vaccine

More than 4 million people have now received the first dose of the COVID-19 vaccine in the UK, according to the latest statistics.

UK funded research essential to get vaccines to the poorest in the world

Professor Melissa Leach, Director, Institute of Development Studies, discusses why UK funded research is important for a successful COVID vaccine roll-out to the poorest and hardest to reach.

Over 70s will begin to receive COVID-19 vaccine today

People aged 70 and over and those clinically extremely vulnerable will be invited to get their COVID-19 vaccinations from today.

UKRI funds new project to investigate COVID-19 mutations

An initial £2.5 million will launch the 'G2P-UK' National Virology Consortium, which will investigate COVID-19 mutations to figure out how they impact vaccines.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders